Skip to main content
. 2014 Aug 17;2014:704207. doi: 10.1155/2014/704207

Table 4.

Base case results (NHS perspective).

SoC Belimumab Difference
Life years 18.99 19.76 0.77
QALYs 10.78 11.31 0.538
Costs €125,234 €142,921 €17,688
ICUR €32,859
ICER €22,990

SoC: standard of care; QALY: quality adjusted life year; ICUR: incremental cost-utility ratio; ICER: incremental cost-effectiveness ratio.